Ignite Creation Date:
2024-05-06 @ 7:40 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02579616
Status:
COMPLETED
Last Update Posted:
2020-12-23
First Post:
2015-10-16
Brief Title:
Study of Lenvatinib E7080 in Unresectable Biliary Tract Cancer BTC Who Failed Gemcitabine-based Combination Chemotherapy
Sponsor:
Eisai Co Ltd
Organization:
Eisai Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-16
First Submit QC Date:
October 16 2015
Study First Post Date:
2015-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-12-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-23
Last Update Post Date Type:
ACTUAL